Printer Friendly

A Study of Recombinant Factor IX in Drosophila Insect S2 Cell Lines Through Transient Gene Expression Technology.

Introduction

The prerequisite step for the mass production of proteins is to develop stable clones from recombinant cells. Because the production of stable clones using cells is a time-consuming complex process, using the Transient Gene Expression (TGE) technique can be of great significance. With the vast developments made in the transferring methods and transient culturing methods, the mass production of recombinant proteins through transient transferring methods seems viable. In fact, implementing faster methods in the production of recombinant proteins is necessary for the study and comparison of different suitable proteins and their variants in terms of their biological features and characteristics. To this end, the TGE technique seems a comparatively more suitable alternative. Compared to Stable Gene Expression (SGE), TGE allows recombinant proteins to be produced in a relatively shorter period of time (usually in 10 days) in the absence of genetic selection of plasmid DNA (1-3).

Although a large number of cell lines have been used for the expression of recombinant proteins, only a limited number of them enjoy the necessary characteristics listed below: l) a high transfection characteristic through the usual methods, 2) an ability to adapt to suspension cultures in serum-free cultures, and 3) cost-effectiveness (4).

Mammalian expression systems like CHO and HEK cells are implemented for the production of human recombinant proteins (4). However, using cells which can easily grow in serum-free cultures is cost effective in that serum is expensive to prepare and its use is usually associated with many complications in the purification process (5). Moreover, this technique is used for cells which show a better growth in suspension cultures than they do in plates (4).

The S2 cell line from Drosophila insect, capable of growth in suspension cultures and serum-free cultures, is a suitable expression system for the production of recombinant proteins using TGE technique (5). The S2 expression system has a number of advantages such as a good growth with a high density, and the ability to grow at room temperature in the absence of [CO.sub.2] (6). Hence, the present study aimed at using the S2 cell lines for the factor IX (FIX) expression through TGE technique, and comparing the results with those obtained through stable expressions.

Materials and Methods

Drosophila Schneider (S2) cells were maintained at 28[degrees]C in the absence of [CO.sub.2] under normal atmosphere in Schneider's insect medium (Sigma-Aldrich) supplemented with penicillin G (50 units/ml) and streptomycin (50 fig/ml) (Sigma-Aldrich). One day prior to trans-fection, [10.sup.9] cells were seeded in a volume of 300 ml in special roller bottles (Sigma), upon which the cells were allowed to loosely adhere. The S2 cells were transfected with pMT-hFIX plasmid employing the calcium phosphate co-precipitation method with minor modifications (7). Cell density and viability were monitored prior to and following transfection by trypan blue exclusion using a 0.4% (w/v) solution.

For the assessment of FIX expression in stable clones, the stable S2-hFIX cells, previously described (8) , were also seeded in special roller bottles with 10 (9) cell/300 ml density. In both transient and stable methods, the FIX expression was screened for 5 days after induction with 0.5 mMCuS04 (9) in the presence of 6 [micro]g vitamin KI/ml/ (10,11).

Human FIX was quantified in conditioned media employing an ELISA (AsserachromIX: Ag, Stago, Switzerland) according to the procedure provided by the manufacturer. Moreover, the functional activity of recombinant hFIX was examined using an aPTT assay as described before ". The activity of expressed hFIX was calculated against the standard curve related to normal human plasma (Iranian blood transfusion organization), with one unit of FIX activity corresponding to the amount of FIX in 1 ml of normal plasma (~ 5 fig/ml).

Results

The results obtained related to the expression of FIX in the culture of stable S2-FIX cells showed that the amount of FIX produced in five consecutive days were 886, 1101, 1368, 1895, and 2113 ng/ml, respectively (Figure 1), indicating an increase in the amount of FIX produced with time. Moreover, the examination of the coagulation time revealed a decreasing trend and when was converted into coagulation activity, it was observed that the coagulation activity increased, with the coagulation activity on the first, second, third, fourth, and fifth days being 0.18, 0.22, 0.27, 0.38, and 0.42 U/ml, respectively (Figure 2).

In transient state, after the transfection and the induction of S2 cells in the culture roller bottles, the expression of FIX produced on the first, second, third, fourth, and fifth days were 1445, 1700, 2231, 2487, 3090 ng/ml, respectively (Figure 1). Moreover, the comparison of the coagulation activity of the recombinant FIX secreted from transient cells over five days revealed a slight increase in coagulation activity. More specifically, the coagulation activity was measured to be 0.29, 0.34, 0.45, 0.50, and 0. 62, on the first, second, third, fourth, and fifth days, respectively (Figure 2).

The comparison of the FIX expression through stable cells with that through TGE revealed that the expression of FIX through TGE over five days was 1.6 times as high as that produced by stable expression through S2 cells on the same days.

Discussion

The results obtained in a large number of studies show that TGE technology can be used for the fast, large scale production of recombinant proteins without going through the complex and time-consuming process associated with the production of stable clones (12,13). For the expression of recombinant proteins by TGE technique, usually cell lines are used which grow better in suspension cultures than in plates. From among all mammalian cell lines, HEK293 cells are the most frequently used ones for a large scale transient expression. The expression of human IgG in HEK293 cells as the first successful large scale TGE resulted in the production of 0.5 gram of IgG in less than ten days (14). Recently, a few research groups reported the successful TGE use in CHO cells which had already adopted to suspension conditions (4). As the serum is very expensive to use in cell culture, and is associated with additional complications in purification process, Derouazi et al offered a large scale TGE method for CHO cells in the absence of serum (15).

Although CHO cells seem to be the first candidate for the expression of recombinant proteins, S2 cells enjoy considerable advantages such as growth in suspension, and no need for serum, making them a good replacement for the large scale fast production of recombinant proteins (5). This was confirmed by previous studies which showed that the amount of recombinant active FIX was higher in S2 cells than that in CHO cells (8,11). Hence, in this study, the possible use of S2 cell lines with the ability to grow in serum-free suspension cultures for the expression of FIX through TGE technique was examined.

The comparison of the expression of FIX from stable cells (S2-FIX) on a large scale with the expression of FIX through TGE technology showed that the expression of FIX through TGE is higher than that through stable system, being about 1.6 times more than that through stable expression from S2 cells. Although the exact reason for this difference is not well understood, the following explanation may be relevant. When the expression construct is inside the S2 cell in both transient and stable states, hundreds of copies of the expression plasmid will spontaneously integrate into the genome in a head to tail fashion (9). However, in expression medium without a selected antibiotic, plasmid stability is observed to be less in stable state. Moreover, cells in the transient state are fresh compared to those in the stable state in that cells need to pass through the selective medium several times in order to acquire the stable status. The counting performed after the induction showed that the viability and the cell density of the stable cells were lower than those of the transient cells.

Similarly, the comparison of the expression of FIX in S2 cells through TGE with that in HEK (16) or CHO cells (17) showed that S2 cells are more efficient.

Conclusion

In conclusion, considering the aim of the present research study, the TGE technology is one of the best modern up-to-date methods for the large scale fast expression of recombinant proteins, and thus it can replace the current methods in that it can be implemented to produce large amounts of protein with comparatively lower costs. Although this method has not been used so far for a large scale expression of coagulation factors, TGE method has been successfully used in the production of other proteins such as TNF (18), IgG (l4), t-PA (13), antibodies (15), secretory, membrane and intracellular proteins (1-3). In all the studies implementing this method, it was emphasized that there are some necessary conditions for the cost-effective large production of recombinant proteins within few days to be possible. Davami showed that TGE is a common method for the expression of recombinant proteins in a short period of time (13). In the same vein, Baldi et al showed the feasibility of the use of TGE technology in high and cost-effective production of recombinant proteins using transient transfection of 20 proteins (12). It must be mentioned that all these studies were performed on mammalian cells. Therefore, due to their ability to grow in serum-free suspension cultures, S2 cells can be used in the large scale production of recombinant proteins through TGE technology.

Acknowledgement

The authors greatly appreciate the gift of Drosophila Schneider (S2) cell line from Dr. Bos (LUMC, Netherland) and Dr. Zomorodipour (NIGEB, Iran). This work has been supported by Hakim Sabzevari University. The authors declare that they have no conflict of interest.

References

(1.) Meissner P, Pick H, Kulangara A, Chatellard P, Friedrich K, Wurm FM. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 2001;75(2): 197-203.

(2.) Geisse S, Henke M. Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. J Struct Funct Genomics 2005;6(2-3):165-170.

(3.) Shi C, Shin YO, Hanson J, Cass B, Loewen MC, Durocher Y. Purification and characterization of a recombinant G-protein-coupled receptor, Saccharomyces cerevisiae Ste2p, transiently expressed in HEK.293 EBNA1 cells. Biochemistry 2005;44(48): 15705-157 J4.

(4.) Graham F, Smiley J, Russell W, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36(l):59-74.

(5.) de Jongh WA, Salgueiro S, Dyring C. The use of drosophila S2 cells in R&d and bioprocessing. Pharm Bio-process 2013;1(2):197-213.

(6.) Bernard AR, Kost TA, Overton L, Cavegn C, Young J, Bertrand M, et al. Recombinant protein expression in a Drosophila cell line: comparison with the baculovirus system. Cytotechnology 1994; 15( 1-3): 139-144.

(7.) Cherbas L, Cherbas P. Transformation of Drosophila cell lines: an alternative approach to exogenous protein expression. Baculovirus and Insect Cell Expression Protocols 2007:317-340.

(8.) Vatandoost J, Bos MH. Efficient expression of functional human coagulation factor IX in stably-transfected Drosophila melanogaster S2 cells; comparison with the mammalian CHO system. Biotechnol Lett 2016;38(10):1691-1698.

(9.) Moraes AM, Jorge SA, Astray RM, Suazo CA, Calderon Riquelme CE, Augusto EF, et al. Drosophila melanogaster S2 cells for expression of heterologous genes: From gene cloning to bioprocess development. Biotechnol Adv 2012;30(3):613-628.

(10.) Bandyopadhyay PK, Clark K, Stevenson BJ, Rivier JE, Olivera BM, Golic KG, et al. Biochemical characterization of Drosophila gamma-glutamyl carboxylase and its role in fly development. Insect Mol Biol 2006;15(2): 147-156.

(11.) Vatandoost J, Zomorodipour A, Sadeghizadeh M, Aliyari R, Bos MH, Ataei F. Expression of biologically active human clotting factor IX in Drosophila S2 cells: y-car-boxylation of a human vitamin K-dependent protein by the insect enzyme. Biotechnol Prog 2012;28(1):45-51.

(12.) Baldi L, Muller N, Picasso S, Jacquet R, Girard P, Thanh HP, et al. Transient gene expression in suspension HEK-293 cells: application to large-scale protein production. Biotechnol Prog 2005;21(1): 148-153.

(13.) Davami F, Eghbalpour F, Barkhordari F, Mahboudi F. Effect of peptone feeding on transient gene expression process in CHO DG44. Avicenna J Med Biotech 2014; 6(3): 147-155.

(14.) Girard P, Derouazi M, Baumgartner G, Bourgeois M, Jordan M, Jacko B, et al. 100-liter transient transfection. Cytotechnology 2002;38(l-3): 15-21.

(15.) Derouazi M, Girard P, Van Tilborgh F, Iglesias K, Muller N, Bertschinger M, et al. Serum-free large-scale transient transfection of CHO cells. Biotechnol Bioeng 2004; 87(4):537-545.

(16.) Azimifar M, Vatandoost J. Large-scale production of recombinant FIX in stable HEK-FIX cells: Islamic Azad University-Sabzevar Branch; 2016. http://theses.iaus.ac. ir/Abstract/thesis-3 83 7 .html

(17.) Baghani A, Vatandoost J. Comparison of recombinant FIX expression in stable CHO-FIX cells in small and large-scale: Islamic Azad University-Sabzevar Branch; 2016. http://theses.iaus.ac.ir/Abstract/thesis-3835.html

(18.) Schlaeger EJ, Christensen K. Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology'l999;30(l-3):71-83.

Jafar Vatandoost (1*) and Kambiz Kafi Sani (2)

(1.) Department of Biology, Hakim Sabzevari University, Sabzevar, Iran

(2.) Department of Biotechnology, Sabzevar Branch, Islamic Azad University, Sabzevar, Iran

(*) Corresponding author:

Jafar Vatandoost, Ph.D.,

Department of Biology, Hakim

Sabzevari University, Sabzevar,

Iran

Tel: +98 51 44013329

Fax: +98 51 44013365

E-mail:

j.vatan@hsu.ac.ir

Received: 27 Apr 2017

Accepted: 1 Jul 2017
COPYRIGHT 2018 Avicenna Research Institute
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Short Communication; Schneider 2 cells
Author:Vatandoost, Jafar; Sani, Kambiz Kafi
Publication:Avicenna Journal of Medical Biotechnology (AJMB)
Article Type:Report
Date:Oct 1, 2018
Words:2233
Previous Article:A Study on the Association between CCR[DELTA]32 Mutation and HCV Infection in Iranian Patients.
Next Article:Rapid and Simple Detection of Escherichia coli by Loop-Mediated Isothermal Amplification Assay in Urine Specimens.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters